Edit concept Question Editor Create issue ticket

Erythropoietic Porphyria

EPP

Erythropoietic porphyria (EP), or congenital erythropoietic porphyria (CEP), results from a deficiency of an enzyme in the pathway for heme synthesis. This leads to the accumulation of toxic porphyrins, which make tissues photosensitive. The major manifestations are blistering skin conditions, often severe and leading to deformities, and hemolytic anemia. Allogeneic bone marrow transplantation is curative.


Presentation

Erythropoietic porphyria (EP) belongs to the porphyria group of disorders. These arise from deficiencies in enzymes that catalyze steps in heme biosynthesis. Manifestations of the disease vary and depend on the metabolic intermediates that accumulate and the organs primarily affected. Based on the main organ involved, the porphyria diseases are classified into hepatic and erythroid groups [1].

EP is a very rare disease that arises because of a deficiency of uroporphyrinogen III synthase. This results in spontaneous formation of type I isomers (uroporphyrinogen I and uroporphyrin I); these are dead-end products, which accumulate mainly in red blood cells, plasma, and bone, and are excreted in urine and feces. Porphyrins are colored, fluoresce in UV light, and cause photosensitivity in biomolecules and damage to tissues.

EP is inherited as an autosomal recessive disorder. Manifestations range from severe cases, detected first as jaundice and pink diaper rash in newborns, or even earlier as intrauterine hydrops due to hemolytic anemia, to milder manifestations in adults.

A characteristic feature of the disease is damage, often severe, to the skin, especially in areas exposed to light (face, hands). There are bullous lesions, which rupture easily and become infected. Repeated damage and infections cause scarring, pigmentation, and thickening of the skin. Epidermal atrophy and destruction of cartilage lead to contractures, loss of digits, and deformities on the face and hands [2]. Hypertrichosis of the face is also common. Damage to the eye [3] may occur because of several reasons, among which are inflammation and lagophthalmos; scarring of the cornea may lead to visual loss or even blindness. The teeth can have a red color because of deposition of porphyrin in them. Porphyrins can also collect in the bones and cause bone loss and deformities.

Hemolysis, which occurs to varying degrees, is probably because the deposition of uroporphyrin I in erythrocytes renders them fragile. This effect leads to hemolytic anemia, splenomegaly, and thrombocytopenia. Compensatory bone marrow expansion can result in fragile bones [4].

Splenomegaly
  • Clinical manifestations can range from mild to severe and include erythrodontia, reddish-colored urine, and hemolytic anemia that can be mild or severe and may result in splenomegaly. Completely avoiding exposure to the sun is crucial.[ncbi.nlm.nih.gov]
  • The consequences of chronic haemolysis are splenomegaly, reactive erythroid hyperplasia, erythrodontia, bone fragility, extreme photosensitivity and photomutilation.[ncbi.nlm.nih.gov]
  • Splenomegaly and hemolytic anemia are typical internal symptoms. Skeletal changes such as osteolysis and calcifications are frequent. Up to date 130 cases of CEP have been published.[ncbi.nlm.nih.gov]
  • Deficiency of this enzyme results in an accumulation of high amounts of uroporphyrin I in all tissues, leading to hemolytic anemia, splenomegaly, erythrodontia, bone fragility, exquisite photosensitivity, and mutilating skin lesions.[ncbi.nlm.nih.gov]
  • Splenomegaly and hemolytic anemia are typical internal symptoms. Skeletal changes such as osteolysis and calcifications are frequent. To date 130 cases of congenital erythropoietic porphyria have been published and are summarized here.[ncbi.nlm.nih.gov]
Anemia
  • Here, we have characterized two novel X-linked CEP patients, both with misleading hematological phenotypes that include dyserythropoietic anemia, thrombocytopenia, and hereditary persistence of fetal hemoglobin.[ncbi.nlm.nih.gov]
  • Deficiency of this enzyme results in an accumulation of high amounts of uroporphyrin I in all tissues, leading to hemolytic anemia, splenomegaly, erythrodontia, bone fragility, exquisite photosensitivity, and mutilating skin lesions.[ncbi.nlm.nih.gov]
  • Severe cases are characterized by extreme photosensitivity, causing scarring and mutilations, and by hemolytic anemia, reducing life expectancy.[ncbi.nlm.nih.gov]
  • Skeletal radiographs revealed features typical of other severe hemolytic anemias, but in addition there was loss of the terminal phalanges of the hand as a result of photomutilation.[ncbi.nlm.nih.gov]
Short Stature
  • stature Decreased body height Small stature [ more ] 0004322 Vertebral compression fractures Compression fracture 0002953 Showing of 40 Last updated: 11/1/2018 The resources below provide information about treatment options for this condition.[rarediseases.info.nih.gov]
Photosensitivity
  • Clinical features include photosensitive blistering and severe anemia. Wood's lamp fluorescence of the diaper is a useful screening test. We describe a severely affected neonate with systemic involvement due to a homozygous mutation.[ncbi.nlm.nih.gov]
  • During early childhood, all the siblings started showing signs of photosensitivity with darkening of urine color followed by skin blistering over the face and hands.[ncbi.nlm.nih.gov]
  • Because of severe cutaneous photosensitivity, treatment of CEP has mainly been focused upon the avoidance of sunlight and trauma of the skin to minimize skin symptoms.[ncbi.nlm.nih.gov]
  • Accumulation of porphyrins results in haemolysis and extensive photosensitivity. The consequences of chronic haemolysis are splenomegaly, reactive erythroid hyperplasia, erythrodontia, bone fragility, extreme photosensitivity and photomutilation.[ncbi.nlm.nih.gov]
  • Congenital erythropoietic porphyria (CEP) is a rare autosomal recessive disorder characterized by uroporphyrinogen III synthase (UROS) deficiency resulting in massive porphyrin accumulation in blood cells, which is responsible for hemolytic anemia and skin photosensitivity[ncbi.nlm.nih.gov]
Blister
  • During early childhood, all the siblings started showing signs of photosensitivity with darkening of urine color followed by skin blistering over the face and hands.[ncbi.nlm.nih.gov]
  • This deficiency leads to hemolytic anemia, photosensitivity, blistering of the skin, and deposition of red-brown pigments in the bones and teeth.[ncbi.nlm.nih.gov]
  • Clinical features include photosensitive blistering and severe anemia. Wood's lamp fluorescence of the diaper is a useful screening test. We describe a severely affected neonate with systemic involvement due to a homozygous mutation.[ncbi.nlm.nih.gov]
  • A 27-year-old male patient was presented with foreign body sensation in both the eyes for 2 years duration and blisters followed by scarring and pigmentation in the photo-exposed areas of the body over the previous 12 years.[ncbi.nlm.nih.gov]
  • A 51-year-old Japanese man and his 56-year-old sister of consanguineous parents had skin lesions with areas of dark-brown pigmentation and blisters with minimal trauma on sun-exposed skin which resembled those seen in porphyria cutanea tarda.[ncbi.nlm.nih.gov]
Skin Lesion
  • A 51-year-old Japanese man and his 56-year-old sister of consanguineous parents had skin lesions with areas of dark-brown pigmentation and blisters with minimal trauma on sun-exposed skin which resembled those seen in porphyria cutanea tarda.[ncbi.nlm.nih.gov]
  • Deficiency of this enzyme results in an accumulation of high amounts of uroporphyrin I in all tissues, leading to hemolytic anemia, splenomegaly, erythrodontia, bone fragility, exquisite photosensitivity, and mutilating skin lesions.[ncbi.nlm.nih.gov]
  • Deficiency of this enzyme results in an accumulation of high amounts of uroporphyrin I in all tissues leading to hemolytic anemia, splenomegaly, erythrodontia, bone fragility, exquisite photosensitivity and mutilating skin lesions.[ncbi.nlm.nih.gov]
  • Congenital erythropoietic porphyria (CEP) is due to a deficiency in the enzymatic activity of uroporphyrinogen III synthase (UROS); such a deficiency leads to porphyrin accumulation and results in skin lesions and hemolytic anemia.[ncbi.nlm.nih.gov]
  • HEP skin lesions.) Figure 2 HEP skin lesions. (From Puy H, Gouya L, Deyback J-C. Porphyrias. Lancet 2010;375:924-37.)[clinicaladvisor.com]
Cutaneous Manifestation
  • Biochemical and molecular studies were undertaken to investigate the nature of the unusually mild phenotype in a 15-year-old boy with only cutaneous manifestations.[ncbi.nlm.nih.gov]
  • Severely affected patients are transfusion dependent and have mutilating cutaneous manifestations. Successful bone marrow transplantation has proven curative, providing the rationale for stem cell gene therapy.[ncbi.nlm.nih.gov]
  • The cutaneous manifestations are similar to those in PCT. They can be the only clinical features of these mixed porphyrias.[patient.info]
Increased Hair Growth
  • Increased hair growth (hypertrichosis) on sun-exposed skin, brownish-colored teeth (erythrodontia), and reddish-colored urine are common. There may be bone fragility due to expansion of the bone marrow and vitamin deficiencies, especially vitamin D.[sema4.com]
  • The most commonly affected areas include the back of the: Hands Forearms Face Ears Neck The symptoms include: Blisters Itching Swelling of the skin Pain Increased hair growth Darkening and thickening of the skin Causes of Porphyria Each type of porphyria[webmd.com]
  • Increased hair growth (hypertrichosis) on sun-exposed skin, and reddish-colored urine are common.[rarediseasesnetwork.org]
  • Blistering and skin ulcers along with increase hair growth and pigmentation can follow chronic sun exposure.[albertaporphyriasociety.weebly.com]
Red Urine
  • Laboratory findings showed mild hemolysis, red urine, increased serum alkaline phosphatase level, and fluorescence of the red blood cell and urine. The histopathology was consistent with porphyria.[ncbi.nlm.nih.gov]
  • During the follow-up, hemolytic anemia and red urine were detected. The levels of porphyrin metabolites were determined at high concentrations in plasma, stool and urine analysis, which were suggestive of congenital erythropoietic porphyria.[ncbi.nlm.nih.gov]
  • They had recurrent skin bullae, scarring on the face and hands, hirsutism, discoloured fluorescent teeth, red urine, increased haemolysis and grossly increased excretion of porphyrin.[ncbi.nlm.nih.gov]
  • A Diagnosis CEP is suspected in individuals (usually newborns) that show the common symptoms Confirmed by measuring porphyrin levels in the individual's blood A blood sample can also be taken to check for genetic mutations Symptoms Red urine in newborns[prezi.com]
  • Frieden Pediatric Dermatology. 2011; : no 4 Red urine and photosensitive skin rash: Not only was our patientæs urine red, but his teeth had a reddish hue, as well. Ghosh, S.K., Bandyopadhyay, D., Haldar, S., Usatine, R.P.[ijdvl.com]

Workup

Children or adults with skin blistering conditions should be tested for EP. Urinary excretion of porphyrins is increased excessively (100-1000 fold) in EP with about 90% being made up of type I isomers [5]. Concentrations of precursors (for example porphobilinogen) are unchanged. Large amounts of porphyrins (mainly coproporphyrins) also appear in the feces. Red blood cells and plasma also contain increased concentrations of porphyrins. Patients with the highest levels of porphyrins are most affected [5].

Both direct and coupled assays for uroporphyrinogen III synthase activity have been developed [6]. Prenatal diagnosis can be performed by measuring uroporphyrinogen III synthase enzyme activity in chorionic villi or cultured amniotic cells [7].

Detection of mutations in the synthase gene can also be used for prenatal diagnosis [8]. The mutations in uroporphyrinogen III synthase are heterogeneous, but there is one mutation (C73R) that is present in 40% of cases [9]. Homozygotes for this mutation have the most severe form of the disease; genotype-phenotype correspondence for other mutations has also been examined [2]. In addition to molecular analyses, examination of porphyrin levels should also be undertaken to assess the likely severity of the disease [10]. An elevated concentration of uroporphyrin I in the amniotic fluid is indicative of EP [8].

Fluorescence microscopy will detect fluorescing nuclei in erythrocyte precursors in EP. Histologic examinations demonstrate cutaneous changes (such as hyalinized walls of blood vessels and caterpillar bodies) that also occur in other porphyrias.

Pericardial Calcification
  • The cause of pericardial calcification could be deposition of porphyrins in the pericardium. Surgical importance of this rare condition is highlighted.[ncbi.nlm.nih.gov]
Soft Tissue Calcification
  • The authors describe a 15-year-old boy in whom the radiologic manifestations of this disorder included the known features of osteopenia, acro-osteolysis, soft-tissue calcifications and widening of the diploic space, as well as the previously unreported[ncbi.nlm.nih.gov]

Treatment

  • We show that a treatment with proteasomal inhibitors, but not with lysosomal inhibitors, could rescue the expression of both EGFP-UROS mutants.[ncbi.nlm.nih.gov]
  • Various methods of treatment have been used to treat CEP with varying success, including erythrocyte transfusion, hydroxyurea, and splenectomy.[ncbi.nlm.nih.gov]
  • Non-absorbable sorbents that bind porphyrins in the gastrointestinal tract may be useful in the treatment of porphyrias whose manifestations result from porphyrin excess.[ncbi.nlm.nih.gov]
  • A single investigator collated data related to treatments and their outcomes in 29 patients with CEP from the U.K., France, Germany and Switzerland.[ncbi.nlm.nih.gov]
  • We further discuss several current and future treatment options for this therapeutically challenging disease.[ncbi.nlm.nih.gov]

Prognosis

  • Congenital erythropoietic porphyria (CEP) is an autosomal recessive photomutilating porphyria with onset usually in childhood, where haematological complications determine prognosis.[ncbi.nlm.nih.gov]
  • The prognosis of CEP is poor with death occurring in early adult life and available treatments are only symptomatic and unsatisfactory.[ncbi.nlm.nih.gov]
  • Prognosis In severe forms hemolytic anemia and, in particular, thrombocytopenia dominate the prognosis and greatly diminish the life expectancy of patients. The multiple fractures often cause mobility disabilities.[orpha.net]
  • What is the Prognosis of Congenital Erythropoietic Porphyria? (Outcomes/Resolutions) The prognosis of Congenital Erythropoietic Porphyria varies with the severity of the condition.[dovemed.com]
  • Prognosis Remarkable clinical variability exists in erythropoietic porphyria. Despite the limited treatments that are currently available, the prognosis is not invariably poor.[emedicine.medscape.com]

Etiology

  • For porphyria etiology and pathophysiology, see Overview of Porphyrias . Resources In This Article[merckmanuals.com]
  • Etiology Congenital erythropoietic porphyria is caused by a deficiency of uroporphyrinogen- synthase (URO-S; the fourth enzyme in the heme biosynthesis pathway) leading to a massive accumulation of isomeric I porphyrins (uro and coproporphyrins) in the[orpha.net]
  • […] founder effect) Onset: puberty to age 30 years CEP: rare, 150 cases reported ( 1 ) Onset: infancy to age 10 years XLP: prevalence 1/700,000 ( 3 , 4 ) Onset: childhood HCP: rare, 1 ) Onset: after puberty ADP: rare, 1 ) Onset: both childhood and adulthood Etiology[unboundmedicine.com]
  • (Etiology) Congenital Erythropoietic Porphyria is caused by one or several mutations in the UROS gene.[dovemed.com]
  • Etiology Erythropoietic porphyria is caused by autosomal recessive inheritance of genes that encode abnormal uroporphyrinogen III synthase (UROS) enzyme protein.[emedicine.medscape.com]

Epidemiology

  • Summary Epidemiology Since its description at the end of the 19th century, about 200 cases have been reported in the literature.[orpha.net]
  • Molecular epidemiology of erythropoietic protoporphyria in the united kingdom. Br J Dermatol. 2010;162:642–6. Minder EI, Schneider-Yin X, Steurer J, Bachmann LM.[rarediseases.org]
  • […] inheritance Deficient enzyme: no. 7 (protoporphyrinogen type III oxidase, mitochondrial, PPOX gene) X-linked protoporphyria (XLP) Chronic; X-linked dominant inheritance Gain-of-function mutation in enzyme no. 1 (ALA synthase, mitochondrial, ALAS2 gene) Epidemiology[unboundmedicine.com]
  • Horner ME et al (2013) Cutaneous porphyrias part I: epidemiology, pathogenesis, presentation, diagnosis, and histopathology.[link.springer.com]
Sex distribution
Age distribution

Pathophysiology

  • For porphyria etiology and pathophysiology, see Overview of Porphyrias . Resources In This Article[merckmanuals.com]
  • .0000000000000330 ERYTHROID SYSTEM AND ITS DISEASES: Edited by Narla Mohandas Abstract Author Information Authors Article Metrics Metrics Many studies over the past decade have together identified new genes including modifier genes and new regulation and pathophysiological[journals.lww.com]
  • Onset: puberty to age 30 years CEP: rare, 150 cases reported ( 1 ) Onset: infancy to age 10 years XLP: prevalence 1/700,000 ( 3 , 4 ) Onset: childhood HCP: rare, 1 ) Onset: after puberty ADP: rare, 1 ) Onset: both childhood and adulthood Etiology and Pathophysiology[unboundmedicine.com]
  • However, further studies to understand the actual pathophysiology of the disease are required.[ojoonline.org]
  • Pathophysiology Erythropoietic porphyria is primarily a disorder of bone marrow heme synthesis.[emedicine.medscape.com]

Prevention

  • We previously demonstrated that the UROS(C73R) mutant protein conserves intrinsic enzymatic activity but triggers premature degradation in cellular systems that could be prevented by proteasome inhibitors.[ncbi.nlm.nih.gov]
  • The literature regarding the dental aspects of this disorder is briefly reviewed and the preventive, restorative, and esthetic dental management of a 4-year-old child with congenital erythropoietic porphyria is described.[ncbi.nlm.nih.gov]
  • It is important to diagnose patients earlyto prevent and minimize complications such asscarring and secondary infection, provide longterm skin checks, and advise patients about lifestylemodification.[ncbi.nlm.nih.gov]
  • When the underlying mechanism is clearly identified, the appropriate therapy can then be instituted to prevent further damage.[ncbi.nlm.nih.gov]
  • […] protein homeostasis is a prevalent mechanism responsible for UROS deficiency and that modulators of UROS proteolysis such as proteasome inhibitors or chemical chaperones may represent an attractive therapeutic option to reduce porphyrin accumulation and prevent[ncbi.nlm.nih.gov]

References

Article

  1. Gross U, Hoffmann GF, Doss MO. Erythropoietic and hepatic porphyrias. J Inherit Metab Dis. 2000 Nov;23(7):641-661.
  2. Desnick RJ, Astrin KH. Congenital erythropoietic porphyria: advances in pathogenesis and treatment. Br J Haematol. 2002 Jun;117(4):779-795.
  3. Hillenkamp J, Reinhard T, Fritsch C, et. al. Ocular involvement in congenital erythropoietic porphyria (Günther's disease): cytopathological evaluation of conjunctival and corneal changes. Br J Ophthalmol. 2001 Mar; 85(3):371
  4. Poh-Fitzpatrick MB. Clinical features of the porphyrias. Clin Dermatol. 1998 Mar-Apr;16(2):251-264.
  5. Freesemann AG, Bhutani LK, Jacob K, Doss MO. Interdependence between degree of porphyrin excess and disease severity in congenital erythropoietic porphyria (Günther's disease). Arch Dermatol Res. 1997 Apr;289(5):272-276.
  6. Tsai SF, Bishop DF, Desnick RJ. Coupled-enzyme and direct assays for uroporphyrinogen III synthase activity in human erythrocytes and cultured lymphoblasts. Enzymatic diagnosis of heterozygotes and homozygotes with congenital erythropoietic porphyria. Anal Biochem. 1987 Oct;166(1):120-133.
  7. Deybach JC, Grandchamp B, Grelier M, et al. Prenatal exclusion of congenital erythropoietic porphyria (Günther's disease) in a fetus at risk. Hum Genet. 1980 Feb;53(2):217-221.
  8. Ged C, Moreau-Gaudry F, Taine L, et. al. Prenatal diagnosis in congenital erythropoietic porphyria by metabolic measurement and DNA mutation analysis. Prenat Diagn. 1996 Jan;16(1):83-86.
  9. Frank J, Wang X, Lam HM, et al. C73R is a hotspot mutation in the uroporphyrinogen III synthase gene in congenital erythropoietic porphyria. Ann Hum Genet. 1998 May;62(Pt 3):225-230.
  10. Sassa S. Modern diagnosis and management of the porphyrias. Br J Haematol. 2006 Nov;135(3):281-292.

Ask Question

5000 Characters left Format the text using: # Heading, **bold**, _italic_. HTML code is not allowed.
By publishing this question you agree to the TOS and Privacy policy.
• Use a precise title for your question.
• Ask a specific question and provide age, sex, symptoms, type and duration of treatment.
• Respect your own and other people's privacy, never post full names or contact information.
• Inappropriate questions will be deleted.
• In urgent cases contact a physician, visit a hospital or call an emergency service!
Last updated: 2018-06-21 22:39